Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication September 12, 2005
- Accepted for publication November 14, 2005
- Published online March 1, 2006.
Copyright & Usage
© 2006 by Society of Nuclear Medicine
Author Information
- Anna Orlova, PhD 1 , 2 ,
- Fredrik Y. Nilsson, PhD 1 , 2 ,
- Maria Wikman, PhD 3 ,
- Charles Widström, MSc 4 ,
- Stefan Ståhl, PhD 3 ,
- Jörgen Carlsson, PhD 2 and
- Vladimir Tolmachev, PhD 1 , 2
- 1Affibody AB, Bromma, Sweden; 2Unit of Biomedical Radiation Sciences, Department of Oncology, Radiology, and Clinical Immunology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden; 3Department of Biotechnology, AlbaNova University Center, Royal Institute of Technology (KTH), Stockholm, Sweden; and 4Section of Hospital Physics, Department of Oncology, Uppsala University Hospital, Uppsala, Sweden
- For correspondence or reprints contact: Vladimir Tolmachev, PhD, Unit of Biomedical Radiation Sciences, Rudbeck Laboratory, 751 85 Uppsala, Sweden. E-mail: valdimir.tolmachev{at}bms.uu.se
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Preclinical and clinical applications of specific molecular imaging for HER2-positive breast cancer
- Local variations of HER2 dimerization in breast cancer cells discovered by correlative fluorescence and liquid electron microscopy
- Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties
- Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain
- Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size
- A 2-Helix Small Protein Labeled with 68Ga for PET Imaging of HER2 Expression
- Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine
- Small-Animal SPECT and SPECT/CT: Important Tools for Preclinical Investigation
- Small-Animal PET Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with Site-Specific 18F-Labeled Protein Scaffold Molecules
- Comparison of the Biodistribution and Tumor Targeting of Two 99mTc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT
- Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications
- Radionuclide Therapy of HER2-Positive Microxenografts Using a 177Lu-Labeled HER2-Specific Affibody Molecule